Advertisement
Cardiovascular
Subscribe to Cardiovascular
View Sample

FREE Email Newsletter

Source Precision Medicine, Inc., dba SourceMDx Assigns All Its Assets to Joseph F. Finn, Jr., C.P.A. of the firm of Finn, Warnke & Gayton, LLP

March 1, 2011 9:35 am | by Bio-Medicine.Org | News | Comments

WELLESLEY HILLS, Mass., March 1, 2011 /- Source Precision Medicine, Inc., dba SourceMDx ("SourceMDx") has assigned all its assets to Joseph F. Finn, Jr., C.P.A. ("Finn") of the firm Finn, Warnke & Gayton, LLP to be liquidated for the benefit of SourceMDx creditors. Source MDx® is...

Pervasis Receives Orphan Drug Designation in Europe for Vascugel® to Prevent Arteriovenous Access Failure in Patients Undergoing Hemodialysis

March 1, 2011 2:36 am | by Bio-Medicine.Org | News | Comments

CAMBRIDGE, Mass., March 1, 2011 /- Pervasis Therapeutics, Inc. announced today that the European Commission (EC) has granted Orphan Drug Designation for Vascugel® for the prevention of hemodialysis vascular access failure in patients with end stage renal disease (ESRD). The...

Glenveigh Medical and Monica Healthcare Announce Distribution Agreement for Groundbreaking FDA Cleared Wireless Fetal Monitoring System

February 28, 2011 8:35 am | by Bio-Medicine.Org | News | Comments

CHATTANOOGA, Tenn., Feb. 28, 2011 /- Glenveigh Medical, LLC and Monica Healthcare Limited today announced an agreement for exclusive distribution rights in the United States as well as US territories and military bases for Monica Healthcare's AN24 wireless fetal monitoring system. The...

Advertisement

Intuity Medical Secures $20M Credit Facility From Silicon Valley Bank and Oxford Finance Corporation

February 28, 2011 3:35 am | by Bio-Medicine.Org | News | Comments

SUNNYVALE, Calif., Feb. 28, 2011 /PRNewswire/ -- Intuity Medical, Inc .™, a privately-held company developing innovative technologies in diabetes management, announced that it has secured a $20M credit facility from Silicon Valley Bank and Oxford Finance Corporation . The funds will...

Hotspur's Keeper Embolectomy Catheter Deployed for First Time

February 28, 2011 2:35 am | by Bio-Medicine.Org | News | Comments

MOUNTAIN VIEW, Calif., Feb. 28, 2011 /- Hotspur Technologies announced today that Dr. Thomas DiBartholomeo of Fairfield, CT, performed the first clinical use of its Keeper™ Embolectomy Catheter.  The Keeper Catheter enables physicians to clear clot formation within arteries,...

A Pacemaker the Size of a Tic Tac

February 27, 2011 7:34 pm | by Massachusetts Institute of Technology | News | Comments

Medtronic is using microelectronics to make a pacemaker so small it can be injected.

Cardiac device maker CardioFocus raises nearly $14M

February 25, 2011 4:35 am | by Mass High Tech: The Journal of New England Technology | News | Comments

CardioFocus Inc. of Marlborough, a maker of laser ablation treatments for atrial fibrillation, has raised $13.64 million of a planned $15.64 million equity round, the company reported in a regulatory filing.

China Pharma Holdings, Inc. to Report Fiscal Year 2010 Financial Results on March 3, 2011

February 25, 2011 4:35 am | by Bio-Medicine.Org | News | Comments

HAIKOU, China, Feb. 25, 2011 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE Amex: CPHI ), which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that it plans to release its fiscal year 2010 financial...

Advertisement

Gen-Probe to Webcast Three Upcoming Investor Presentations

February 25, 2011 1:35 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Feb. 24, 2011 /- Gen-Probe Incorporated (Nasdaq: GPRO ) announced today that the Company will present at three upcoming investor conferences: RBC Capital Markets' Healthcare Conference in New York at 10 a.m. Eastern Time (ET) on March 2.  The Company also will participate...

Reportlinker Adds Global ECG Telemetry Devices Industry

February 24, 2011 6:35 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Feb. 24, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global ECG Telemetry Devices Industry http://www.reportlinker.com/p090653/Global-ECG-Telemetry-Devices-Industry.html This report analyzes the worldwide markets for ECG...

Reportlinker Adds Global Cardiac Defibrillators Industry

February 24, 2011 6:35 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Feb. 24, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Cardiac Defibrillators Industry http://www.reportlinker.com/p098394/Global-Cardiac-Defibrillators-Industry.html This report analyzes the worldwide markets for...

Reportlinker Adds Global Special Purpose Needles Industry

February 24, 2011 6:35 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Feb. 24, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Special Purpose Needles Industry http://www.reportlinker.com/p098381/Global-Special-Purpose-Needles-Industry.html This report analyzes the worldwide markets for...

Reportlinker Adds Global Drug-Eluting Stents Industry

February 24, 2011 4:34 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Feb. 24, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Drug-Eluting Stents Industry http://www.reportlinker.com/p080457/Global-Drug-Eluting-Stents-Industry.html This report analyzes the worldwide markets for...

Advertisement

American Medical Systems Announces U.S. Launch of Concealâ„¢ Low Profile Reservoir for Penile Prosthetics

February 24, 2011 4:34 am | by Bio-Medicine.Org | News | Comments

MINNETONKA, Minn., Feb. 24, 2011 /- American Medical Systems® (AMS) (Nasdaq: AMMD ), a leading provider of world-class devices and therapies for male and female pelvic health, today announced the full U.S. launch of its new Conceal™ Low Profile Reservoir, an enhancement to the...

HeartWare International Reports Fourth Quarter 2010 Revenues of $20.9 Million; 71% Increase From $12.2 Million In Fourth Quarter 2009

February 24, 2011 3:37 am | by Bio-Medicine.Org | News | Comments

FRAMINGHAM, Mass. and SYDNEY, Feb. 24, 2011 /- HeartWare International, Inc. (Nasdaq: HTWR ; ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced revenues of $20.9...

Royal Fornia Electronic Device Co., Ltd. Signs Technology Licensing Agreement to Integrate Masimo rainbow SET Pulse CO-Oximetry Into New Patient Monitors

February 24, 2011 3:37 am | by Bio-Medicine.Org | News | Comments

IRVINE, Calif. and GUANGDONG PROVINCE, China, Feb. 24, 2011 /- Masimo (Nasdaq: MASI ) and Royal Fornia Electronic Device Co., Ltd. jointly announce a worldwide technology licensing agreement to integrate Masimo rainbow SET® Pulse CO-Oximetry™ technology into Royal Fornia's new...

NewCardio Study Shows CardioBip Detects Recurrent Atrial Fibrillation Earlier and More Reliably than Periodic Holter Monitoring(2)

February 24, 2011 3:36 am | by Bio-Medicine.Org | News | Comments

SANTA CLARA, Calif., Feb. 24, 2011 /- PR Newswire – NewCardio, Inc., (OTC Bulletin Board: NWCI ) a cardiovascular diagnostic solutions developer, announced today that the Company has been invited by the Heart Rhythm Society (HRS) to present results of a recent clinical study showing...

Support the Have a HeArt Benefit, Feb. 25

February 23, 2011 12:35 pm | by Arizona State University | News | Comments

ASU's College of Nursing & Health Innovation is hosting a "Have a HeART Benefit," Feb. 25, with proceeds going to the College's NP Healthcare Clinics.read more

Dave Anderson and William Thomsen Join SRI International's Center for Advanced Drug Research to Lead Programs in Proteomics and Metabolic Disease Drug Discovery

February 23, 2011 9:34 am | by Bio-Medicine.Org | News | Comments

MENLO PARK, Calif., Feb. 23, 2011 /- SRI International, an independent nonprofit research and development organization, announced today that two new principal scientists, Dave Anderson, Ph.D., and William Thomsen, Ph.D., have joined its Center for Advanced Drug Research (CADRE) in...

Novo Nordisk Submits First Recombinant Treatment for Factor XIII Deficiency for U.S. Regulatory Approval

February 23, 2011 8:34 am | by Bio-Medicine.Org | News | Comments

PRINCETON, N.J., Feb. 23, 2011 /- Novo Nordisk announced today that a Biologic License Application (BLA) has been submitted to the U.S. Food and Drug Administration (FDA) requesting the approval of a recombinant factor XIII compound (rFXIII) for the vast majority of patients with...

Regeneron Announces March 2011 Investor Conference Presentations

February 23, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

TARRYTOWN, N.Y., Feb. 23, 2011 /- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ) will webcast management presentations at the following investor conferences: Citi 2011 Global Healthcare Conference at 9:00 a.m. Eastern Time on Tuesday, March 1, 2011 RBC Capital Markets' 2011 Healthcare...

Regado Biosciences to Present at the 2011 RBC Capital Markets Healthcare Conference in New York City

February 23, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

BASKING RIDGE, N.J., Feb. 23, 2011 /- Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced that Ellen McDonald, MBA, Senior Vice President and Chief Business Officer, will be speaking and participating on a...

Xenogenics Corporation Retains the Emmes Group to Advise on Fund Raising Efforts

February 23, 2011 6:33 am | by Bio-Medicine.Org | News | Comments

WOONSOCKET, R.I., Feb. 23, 2011 /- Xenogenics Corporation ("Xenogenics"), a majority owned subsidiary of MultiCell Technologies, Inc. (OTC Bulletin Board MCET), is pleased to announce it has retained the Emmes Group to assist with the development and execution of its capital formation...

Abaxis, Inc. to Present at RBC Capital Markets' Healthcare Conference

February 23, 2011 5:35 am | by Bio-Medicine.Org | News | Comments

UNION CITY, Calif., Feb. 23, 2011 /- Abaxis, Inc. (Nasdaq: ABAX ), a medical products company manufacturing point-of-care blood analysis systems, announced today that Clint Severson, chairman and chief executive officer, will present at the RBC Capital Markets' Healthcare Conference on...

Isis Pharmaceuticals Reports That Its Selective CRP Inhibitor Demonstrated Activity in a Phase 1 Study

February 23, 2011 3:34 am | by Bio-Medicine.Org | News | Comments

CARLSBAD, Calif., Feb. 23, 2011 /- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ) announced today the results from a Phase 1 clinical trial in which ISIS-CRPRx produced statistically significant reductions in C-reactive protein (CRP) in the cohort of subjects in the study with elevated CRP....

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading